X
Xuesong Jiang
Researcher at Nanjing Medical University
Publications - 28
Citations - 638
Xuesong Jiang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Nasopharyngeal carcinoma & Metastasis. The author has an hindex of 14, co-authored 27 publications receiving 485 citations.
Papers
More filters
Journal ArticleDOI
Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center
Li-Rong Wu,Yatian Liu,Ning Jiang,Yan-Xin Fan,Jing Wen,Shengfu Huang,Wen-Jie Guo,Xiuhua Bian,Feijiang Wang,Feng Li,Dan Song,Jianfeng Wu,Xuesong Jiang,Juying Liu,Xia He +14 more
TL;DR: IMRT could achieve satisfactory survival outcomes for NPC patients with acceptable late toxicities, however, distant control still remains poor, especially for patients with N3 disease.
Journal ArticleDOI
Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies.
TL;DR: It is suggested that metformin use appears to be associated with a significant reduction in the cancer risk and BCR of prostate cancer, but not in all-cause mortality of patients with prostate cancer.
Journal ArticleDOI
miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
Huaping Xiong,Ting Yan,Weijie Zhang,Fangfang Shi,Xuesong Jiang,Xiaohua Wang,Shoushan Li,Ying Chen,Cheng Chen,Yichao Zhu +9 more
TL;DR: MiR-613 weakens the resistance of TNBC cells against paclitaxel rather than adriamycin, cyclophosphamide, docetaxel, and kaempferol and is involved in cell migration and invasion of T NBC cells via targeting Daam1/RhoA signaling pathway.
Journal ArticleDOI
MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Ning Jiang,Xuesong Jiang,Zhenzhang Chen,Xue Song,Li-Rong Wu,Dan Zong,Dan Song,Li Yin,De-Jun Wang,Cheng Chen,Xiuhua Bian,Xia He +11 more
TL;DR: The newly identified miR-203a-3p/LASP1 pathway provides further insights into the initiation and progression of NPC, which may represent a novel therapeutic target for NPC.
Journal ArticleDOI
Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1
Shoushan Li,Ting Yan,Rong Deng,Xuesong Jiang,Huaping Xiong,Yuan Wang,Qiao Yu,Xiaohua Wang,Cheng Chen,Yichao Zhu +9 more
TL;DR: The low dose of kaempferol inhibits the migration and invasion of TNBC cells via blocking RhoA and Rac1 signaling pathway.